rs8176166

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000357654.9(BRCA1):​c.4185+2684A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.144 in 152,132 control chromosomes in the GnomAD database, including 1,776 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.14 ( 1776 hom., cov: 31)

Consequence

BRCA1
ENST00000357654.9 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel B:1

Conservation

PhyloP100: 0.138
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 17-43088260-T-C is Benign according to our data. Variant chr17-43088260-T-C is described in ClinVar as [Benign]. Clinvar id is 209427.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr17-43088260-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
BRCA1NM_007294.4 linkuse as main transcriptc.4185+2684A>G intron_variant ENST00000357654.9 NP_009225.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
BRCA1ENST00000357654.9 linkuse as main transcriptc.4185+2684A>G intron_variant 1 NM_007294.4 ENSP00000350283 P4P38398-1

Frequencies

GnomAD3 genomes
AF:
0.144
AC:
21882
AN:
152014
Hom.:
1770
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0885
Gnomad AMI
AF:
0.193
Gnomad AMR
AF:
0.188
Gnomad ASJ
AF:
0.157
Gnomad EAS
AF:
0.0913
Gnomad SAS
AF:
0.307
Gnomad FIN
AF:
0.183
Gnomad MID
AF:
0.161
Gnomad NFE
AF:
0.152
Gnomad OTH
AF:
0.159
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.144
AC:
21901
AN:
152132
Hom.:
1776
Cov.:
31
AF XY:
0.149
AC XY:
11118
AN XY:
74370
show subpopulations
Gnomad4 AFR
AF:
0.0883
Gnomad4 AMR
AF:
0.188
Gnomad4 ASJ
AF:
0.157
Gnomad4 EAS
AF:
0.0910
Gnomad4 SAS
AF:
0.307
Gnomad4 FIN
AF:
0.183
Gnomad4 NFE
AF:
0.152
Gnomad4 OTH
AF:
0.164
Alfa
AF:
0.146
Hom.:
263
Bravo
AF:
0.137
Asia WGS
AF:
0.213
AC:
742
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Breast-ovarian cancer, familial, susceptibility to, 1 Benign:1
Benign, reviewed by expert panelcurationEvidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)Jan 12, 2015Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07517 (Asian), 0.04878 (African), 0.1702 (European), derived from 1000 genomes (2012-04-30). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
4.8
DANN
Benign
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs8176166; hg19: chr17-41240277; API